BofA Securities Downgrades Turnstone Biologics (TSBX) to Underperform
Tweet Send to a Friend
(Updated - November 15, 2024 6:13 AM EST)
BofA Securities analyst Charlie Yang downgraded Turnstone Biologics (NASDAQ: TSBX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BofA Securities analyst Charlie Yang downgraded Turnstone Biologics (NASDAQ: TSBX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
